Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Floseal for Prevention of Pelvic Lymphocele in Gynecologic Cancer
NCT01974193Phase 3Unknown
- Sponsor
- Ewha Womans University Mokdong Hospital
- Start
- Dec 2013
- Primary completion
- Dec 2015
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of gelatin + thrombin in pelvic lymphocele (2 arms), sponsored by Ewha Womans University Mokdong Hospital. Primary endpoint: Frequency of pelvic lymphocele at 6 months. Status: unknown.
02
Drugs
gelatin + thrombin
03
Conditions
pelvic lymphocele
Beyond the preview
Go deeper on NCT01974193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01974193.